Bicara Therapeutics Inc. Common Stock (BCAX) — Financial Flexibility Index
Bicara Therapeutics Inc. Common Stock (BCAX) has a Financial Flexibility Index of -0.94x as of March 2026. Free cash flow of $-37.45 Million (operating CF $-37.51 Million minus capex $60.00K) represents -1% of total liabilities ($39.64 Million). Check how strategically is Bicara Therapeutics Inc. Common Stock's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bicara Therapeutics Inc. Common Stock Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for Bicara Therapeutics Inc. Common Stock across 4 annual periods. See BCAX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Bicara Therapeutics Inc. Common Stock (2022–2025)
Year-by-year free cash flow to debt coverage for Bicara Therapeutics Inc. Common Stock. For the full company profile including market capitalisation, see market value of Bicara Therapeutics Inc. Common Stock.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.61x | $-106.55 Million | $-106.83 Million | $29.54 Million | ▼ -273.4% |
| 2024 | -0.97x | $-74.68 Million | $-74.75 Million | $77.32 Million | ▲ +66.8% |
| 2023 | -2.91x | $-45.04 Million | $-45.63 Million | $15.47 Million | ▼ -118.9% |
| 2022 | -1.33x | $-31.88 Million | $-32.08 Million | $23.98 Million | — |